Matches in Nanopublications for { ?s ?p "DDI between Sparfloxacin and Thiothixene - May cause additive QTc-prolonging effects. Increased risk of ventricular arrhythmias. Consider alternate therapy. Thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB01208_DB01623]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01208_DB01623 label "DDI between Sparfloxacin and Thiothixene - May cause additive QTc-prolonging effects. Increased risk of ventricular arrhythmias. Consider alternate therapy. Thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB01208_DB01623]" assertion.